Robert Ennis, MD
Endocrinology, Diabetes & Metabolism · Meridian, IDNPI 1366647729
Payments from drug & device makers
Across 484 payments — averaging $141.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$64K
- Novo Nordisk$1K
- Amgen$674
- Corcept Therapeutics$453
- Antares Pharma, Inc.$413
- Dexcom, Inc.$338
- plus $2K from 30 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 156 | $63,636 |
| Novo Nordisk | 125 | $1,105 |
| Amgen(2 entities) | 24 | $674 |
| Corcept Therapeutics | 24 | $453 |
| Antares Pharma, Inc. | 47 | $413 |
| Dexcom, Inc. | 11 | $338 |
| AstraZeneca(2 entities) | 17 | $322 |
| Abbott | 8 | $240 |
| Sanofi-aventis U.S. LLC | 12 | $205 |
| Amarin Pharma, Inc. | 4 | $163 |
| Insulet Corporation | 8 | $150 |
| Radius Health, Inc. | 7 | $122 |
| Tandem Diabetes Care, Inc. | 5 | $94 |
| Medtronic(2 entities) | 4 | $68 |
| Merck | 4 | $62 |
| Novartis | 3 | $56 |
| Ascendis Pharma Endocrinology Inc | 2 | $47 |
| Senseonics, Incorporated | 1 | $41 |
| Recordati_rare_diseases_inc. | 2 | $35 |
| Arbor Pharmaceuticals, Inc. | 2 | $33 |
| Boehringer Ingelheim | 1 | $26 |
| Johnson & Johnson | 2 | $25 |
| Companion Medical, Inc. | 1 | $24 |
| Nestle Healthcare Nutrition Inc. | 1 | $21 |
| Boston Scientific | 1 | $20 |
| Chiesi USA, Inc. | 1 | $19 |
| Exact Sciences | 1 | $17 |
| AbbVie | 1 | $17 |
| Halozyme Inc | 1 | $17 |
| EUSA Pharma (US) LLC | 1 | $17 |
| Alnylam Pharmaceuticals Inc. | 1 | $16 |
| Pfizer | 1 | $16 |
| Zealand Pharma US, Inc. | 1 | $15 |
| Axsome Therapeutics, Inc. | 1 | $14 |
| Therapeuticsmd, Inc. | 1 | $12 |
| Mayne Pharma Commercial LLC | 2 | $10 |
How this compares
Too few endocrinology, diabetes & metabolism providers in Idahoto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other endocrinology, diabetes & metabolism in Meridian
- Lynn Ge-ZerbeMeridian$9K
- Michael HolyoakMeridian$2K
- Johannes VeldhuisMeridian$80
- David LiljenquistIdaho Falls$16.8M
- Carl VanceIdaho Falls$3.5M
- John LiljenquistIdaho Falls$554K
- Theodore RooseveltBoise$65K
- Julie FooteBoise$8K
- Katy ConnleyEagle$6K
- Adam LykoPost Falls$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.